Septerna SEPN 深 沪
等待开盘 07-15 09:30:00 美东时间
34.54
+0.180
+0.52%
华盛通- 最 高35.37
- 今 开34.27
- 成交量 65.08万股
- 最 低 33.54
- 昨 收 34.36
- 总市值 15.57亿
- 52周最高 38.04
- 市盈率 静 --
- 换手率 1.44%
- 52周最低 10.6161
- 委 比 77.06%
- 总股本 4507.55万
- 历史最高 38.04
- 量 比 0.92
- 振 幅 5.33%
- 历史最低 4.17
- 每 手 1
- 风险率 6.69%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多DigitalOcean, Agios Pharmaceuticals, Kingsoft Cloud And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Nasdaq Composite falling around 1% on Tuesday. Shares of DigitalOcean Holdings Inc (NYSE:DOCN) rose sharply after the company announced it expects a year-over-year increase in second-quarter revenue growth results. Also, the company expects to be at or above the top ...
07-07 22:00
美股大行评级 | 潜在涨幅392.61%！Chardan Capital维持EyePoint"买入"评级，上调目标价至65美元
今日重点评级关注：Chardan Capital：维持EyePoint"买入"评级，目标价从29美元升至65美元；康托·菲茨杰拉德：维持Hyperliquid Strategies"超配"评级，目标价从8美元升至18.4美元
07-02 18:41
Truist Securities Maintains Buy on Septerna, Raises Price Target to $43
Truist Securities analyst Srikripa Devarakonda maintains Septerna (NASDAQ:SEPN) with a Buy and raises the price target from $35 to $43.
07-01 19:53
坎托·菲茨杰拉德重申对Septerna, Inc.（SEPN）的买入评级
坎托·菲茨杰拉德五星分析师约书亚·希默维持塞普特纳公司“买入”评级，目标价60.00美元，塞普特纳昨日收盘价为34.75美元。希默的投资推荐平均回报率为20....
06-30 21:53
分析师看好以下科技股 超威半导体AMD、Septerna Inc. SEPN
两名分析师分别对AMD与SEPN给出看涨评级，释放科技板块乐观信号。 AMD相关关键数据：富国银行分析师亚伦·拉克尔斯重申买入评级，目标价615美元，该股上周一...
06-30 19:11
Septerna Chief People Officer Samira Shaikhly sells 6,250 shares worth $219,224.38
Septerna Chief People Officer Samira Shaikhly sells 6,250 shares worth $219,224.38 Septerna Chief People Officer Samira Shaikhly exercised stock options for 6,250 shares at $11.7 on June 12, 2026. Shaikhly sold 6,250 shares at a weighted average price of $35.08 in the same session. Her direct common
06-17 08:32
美股大行评级 | 存储再获看多！美光、闪迪、西部数据获机构上调目标价；次新股Cerebras、Blackstone、EagleRock获多家机构首予买入平均
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从5.25美元升至5.5美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9美元升至9.25美元
06-09 11:33
Protego Biopharma names Jae B. Kim as chief medical officer
Protego Biopharma names Jae B. Kim as chief medical officer Forbion portfolio company Protego Biopharma appointed Jae B. Kim as chief medical officer, effective immediately. Kim joins from Septerna, where he served as chief medical officer since 2024. Appointment supports Protego’s plan to move lead
06-08 22:20
Septerna Announces First Detailed Preclinical Characterization Of SEP-479 Accepted For Oral Presentation At ENDO 2026
Septerna, Inc. (NASDAQ:SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that the first detailed preclinical characterization of
06-08 20:05
New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity Market
PatentVest's report highlights the rapid expansion of triple-agonist programs in obesity therapeutics, with 27 global projects across major pharma companies and emerging biotechs. The study emphasizes the shift from clinical outcomes to intellectual property strategies, receptor engineering, and delivery systems as key factors shaping the next phase of competition. China is a significant player in this pipeline expansion. Companies like Eli Lilly...
05-08 14:30
